1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Catalyst Pharmaceuticals Inc (CPRX)
  7. Quote

CPRX CPRX

Catalyst Pharmaceuticals Stock Price

6.86
-0.20 (-2.83%)
Upgrade to Real-Time
Afterhours (Closed)
6.86
Volume 902,748
Bid Price 6.75
Ask Price 7.25
News (1)
Day High 7.12

Low
3.27

52 Week Range

High
7.58

Day Low 6.79
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Catalyst Pharmaceuticals Inc CPRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.20 -2.83% 6.86 00:00:04
Open Price Low Price High Price Close Price Prev Close
7.08 6.79 7.12 6.86 7.06
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,974 902,748 $ 6.93 $ 6,257,034 - 3.27 - 7.58
Last Trade Time Type Quantity Stock Price Currency
18:03:28 4 $ 6.86 USD

Period:

Draw Mode:

Catalyst Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 707.39M 103.12M 95.58M $ 119.07M $ 37.10M 0.71 17.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -512.00k 9.30%

more financials information »

Catalyst Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CPRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.357.426.796.99869,793-0.49-6.67%
1 Month6.287.586.077.08980,1810.589.24%
3 Months5.047.584.816.15904,9091.8236.11%
6 Months5.517.584.815.89940,5571.3524.5%
1 Year3.5787.583.274.801,284,6363.2891.73%
3 Years2.717.671.854.321,753,3804.15153.14%
5 Years1.097.671.013.921,422,5805.77529.36%

Catalyst Pharmaceuticals Description

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with the lambert-eaton myasthenic syndrome.


Your Recent History
NASDAQ
CPRX
Catalyst P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.